[1]
2022. SOFT VERSUS HARD OCCLUSAL SPLINT THERAPY IN THE MANAGEMENT OF TEMPOROMANDIBULAR DISORDERS (TMDS). Journal of Pharmaceutical Negative Results. (Dec. 2022), 3183–3187. DOI:https://doi.org/10.47750/pnr.2022.13.S08.393.